{
  "retracted": false,
  "timestamp": 1479945600000,
  "updates": [
    {
      "timestamp": 1585334855579,
      "identifier": {
        "doi": "10.1182/blood-2016-10-745448"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1182/blood-2013-09-529537"
  },
  "publisher": "American Society of Hematology",
  "title": "Gill S, Tasian SK, Ruella M, et al. Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptorâ€“modified T cells. Blood. 2014;123(15):2343-2354."
}
